meRfi® logo
Medical Research Finder
House iconIcon chat dots
Icon question circle

meRfi®-GM

Belantamab mafodotin

Welcome to meRfi-GM!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Navigation

Contents

Belantamab mafodotin is a first-in-class antibody–drug conjugate directed at B-cell maturation antigen and has shown promising activity in clinical trials.
Sheikh et al. 2020 Future Oncology 16: 2783–2798